Assessment of the PARP inhibitor talazoparib photosafety profile

Mateos-Pujante, A; Jiménez, MC; Andreu, I

Jiménez, MC; Andreu, I (通讯作者)，Univ Politecn Valencia, Dept Quim, Camino Vera S-N, Valencia 46022, Spain.

BIOMEDICINE & PHARMACOTHERAPY, 2023; 167 ():

Abstract

Talazoparib (TLZ) is a poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitor employed for the treatment of breast cancer. This drug displays a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索